News

June 12, 2017June 12, 2017

Eureka, City of Hope to Conduct Phase 1 Trial of Investigational CAR T-cell Therapy for Liver Cancer

Liver cancer, News

Eureka Therapeutics and City of Hope will jointly conduct a Phase 1 clinical trial of assessing Eureka’s investigational CAR T-cell therapy ET1402 for hepatocellular carcinoma (HCC), the most common type of liver cancer. “The ... Read more

June 9, 2017June 9, 2017

ProSciento and OWL Metabolomics Team Up to Accelerate NAFLD/NASH Trial Recruitment

News

ProSciento and OWL Metabolomics announced an exclusive, long-term partnership to identify eligible participants for clinical trial enrollment to evaluate therapeutic candidates for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), ... Read more

June 8, 2017

Oral Therapy, VK2809, Shows Potential in Treating NASH-related Fibrosis in Early Study

News, Non-alcoholic fatty liver disease, Non-alcoholic steatohepatitis

The investigative therapy VK2809 showed promising results in an animal study of non-alcoholic steatohepatitis (NASH), a type of non-alcoholic fatty liver disease, Viking Therapeutics, its developer, announced. The treatment’s safety and efficacy ... Read more

June 7, 2017June 7, 2017

SIR-Spheres Radiation Microspheres Outperform Chemo in Liver Cancer Trial

News

SIR-Spheres radiation microspheres shrank the tumors of a significantly larger number of liver cancer patients than the standard-of-care chemotherapy Nexavar (sorafenib), according to a Phase 3 clinical trial. The microspheres, which ... Read more

June 6, 2017June 6, 2017

Ocera Starts Second Part of Trial of OCR-002 for Liver Disease That Impacts Mental Functioning

News

Ocera Therapeutics has started the second part of a Phase 1/2a clinical trial of OCR-002 (ornithine phenylacetate) tablets as a treatment for a liver disease known as hepatic encephalopathy (HE). ... Read more

June 5, 2017June 5, 2017

Australian Researchers Investigate Zinc as Potential Ally Against Liver Disease

News

A study by Australia’s Westmead Institute has revealed an unexpected role for zinc in liver disease. Researchers at the institute’s Storr Liver Center showed that zinc is a strong ... Read more

June 2, 2017June 2, 2017

Digital Support Platform IO Loop Keeps Oncologists and Patients Engaged Throughout Treatment

News

A new digital support platform, IO Loop, is helping patients stay connected online with doctors before, during, and after treatment. This helps patients track symptoms, allows for more personalized ... Read more

June 1, 2017June 1, 2017

Drinking More Coffee Can Reduce Risk of Hepatocellular Carcinoma, Scottish Study Finds

News

Coffee consumption can dramatically cut one’ risk of developing hepatocellular carcinoma (HCC), a type of liver cancer, say researchers from Scotland’s University of Edinburgh who surveyed past studies and ... Read more

May 31, 2017May 31, 2017

FDA Grants Priority Review Status to Opdivo Application for Advanced Liver Cancer Patients

Liver cancer, News

The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) submitted by Bristol-Myers Squibb seeking approval for Opdivo (nivolumab) to treat patients ... Read more

May 30, 2017

Health Canada Approves Ocaliva for Autoimmune Liver Disease Patients

News

Canadian patients with the autoimmune liver disease primary biliary cholangitis (PBC) saw the first approval of a new drug for their condition in more than 20 years, as Health ... Read more